One-in-five women would consider breast removal

Key points
- Twenty percent of women would consider having both their breasts removed to reduce their odds of developing cancer, according to a survey on Monday.
- More than 1,500 women around the world were questioned in the poll about what choices they would make if told they were at high risk of the disease.
- "It is extremely rare for women to undergo a double mastectomy for preventive reasons and, as an option, it is most relevant to women with a very strong family history of breast cancer," said Dr Lesley Walker, of the charity Cancer Research UK.
- Each year more than a million women worldwide are diagnosed with breast cancer.
Twenty percent of women would consider having both their breasts removed to reduce their odds of developing cancer, according to a survey on Monday.
More than 1,500 women around the world were questioned in the poll about what choices they would make if told they were at high risk of the disease.
"It is extremely rare for women to undergo a double mastectomy for preventive reasons and, as an option, it is most relevant to women with a very strong family history of breast cancer," said Dr Lesley Walker, of the charity Cancer Research UK.
Each year more than a million women worldwide are diagnosed with breast cancer. It accounts for 10 percent of all cancers and 23 percent of female cancer, according to the charity.
The poll, conducted by global market agency NOP World, involved women in Australia, Belgium, Brazil, Germany, Italy and Britain.
Having a family history of breast cancer, an early puberty, late Menopause, obesity and not having children can increase the risk of developing the illness.
Nearly half the women questioned said they were worried about developing breast cancer. In Britain about 60 percent admitted their fear of the illness.
Scientists at Cancer Research UK are enlisting 6,000 Postmenopausal women worldwide to take part in a trial to see if the drug anastrozole, or Arimidex made by AstraZeneca Plc, can prevent the disease.
The drug works by stopping the production of the female hormone oestrogen, which is an important cause of the illness.
"With over 30,000 post-menopausal women being diagnosed with breast cancer in the UK every year, it's vital that we look for effective ways of preventing the disease," said Professor Jack Cuzick, of Cancer Research UK, who is the lead researcher.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsAnesthetic technique improves quality of recovery for women having breast cancer surgery
Anesthesiologists using a technique similar to a dental freeze can improve the quality of recovery and decrease recovery time for breast cancer surgery patients, according to a new study. The study, from researchers at…
12 March 2014
NewsNew presurgery combination therapy may improve outcomes for women with triple-negative breast cancer
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly…
17 December 2013
NewsBreast cancer risk related to changes in breast density as women age
Automated breast density measurement is predictive of breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women as they age, according to research being…


